Peer-influenced content. Sources you trust. No registration required. This is HCN.
GoodRx Health
The introduction of lisdexamfetamine, a generic for Vyvanse, initially showed promise in increasing access to ADHD treatment. However, it too has fallen into shortage, highlighting the ongoing challenges in meeting patient demand.
Family Medicine/General Practice September 3rd 2024